CSL Ltd. Newsletter
-
Alpha 1 Lung Disease Market Recent Trends and Developments Analysis | Scope of Current and Future Industry 2031|
16 May 2024 07:15 GMT
… , Takeda Pharmaceutical Company Limited., CSL Behring, Vertex Pharmaceuticals Incorporated, … AbbVie Inc., and Regeneron Pharmaceuticals Inc.
Segment Analysis : … Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
Market Geography: …
-
Influenza Vaccines Market to Exhibit a Remarkable CAGR of 7.1% by 2031,Trends, Key Drivers, and Opportunity Analysis.
15 May 2024 07:39 GMT
… :
CSL Seqirus, GlaxoSmithKline plc, Sanofi, AstraZeneca, FluGen Inc., Moderna Inc., Biocryst Pharmaceuticals …
-
Triple combination COPD therapy lowers risk for cardiopulmonary outcomes
19 May 2024 19:14 GMT
… , BIAL, Boehringer Ingelheim, Chiesi, Cipla, CSL Behring, EpiEndo, Genentech, GlaxoSmithKline, Glenmark … , Teva, Theravance Biopharma and Verona Pharma.
Add topic to email alerts …
-
Unilever appoints new independent non-executive directors
18 May 2024 20:18 GMT
… executive director/COO at CSL Stockbrokers Limited before he served … , New York, and Pfizer Global Pharmaceuticals (PGP) Planning and Business Development …
-
Unilever Nigeria appoints Bolaji Balogun as chairman
18 May 2024 12:03 GMT
… Executive Director/COO at CSL Stockbrokers Limited. Bolaji was Executive … , New York, and Pfizer Global Pharmaceuticals (PGP) Planning and Business Development …
-
Can the centre hold?
17 May 2024 10:46 GMT
… to shootings linked to the drug trade in the capital. In … at the chamber of employees (CSL) and elect the members of …
-
Do We Have Enough Bird Flu Vaccines for a Potential Pandemic?
16 May 2024 17:57 GMT
… , the federal government, pharmaceutical companies and researchers are … partnerships with three pharmaceutical companies: GSK, CSL Seqirus and Sanofi. … to a company spokesperson, CSL Seqirus’s vaccine manufacturer, … says. “We need drugs that will be our first …
-
Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences
15 May 2024 20:14 GMT
… ) and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus … for innovative mRNA vaccines with CSL Seqirus, and a joint venture …
-
Non-Cystic Fibrosis Bronchiectasis Pipeline Assessment 2024: FDA, EMA, PDMA Approvals, Clinical Trials, Therapies, MOA, ROA By Delveinsight | NP339, CHF 6333, CSL787, HSK31858, S-1226, Benralizumab
15 May 2024 12:32 GMT
… Parion Sciences, Chiesi Farmaceutic, CSL Behring, Haisco Pharmaceutical, SolAeroMed Inc., AstraZeneca, … Emerging Non-Cystic Fibrosis Bronchiectasis Drugs Under Different Phases of … However, challenges Associated with the Drug Delivery, regulatory & …
-
Stocks that will see action today—May 15, 2024
15 May 2024 02:35 GMT
… CRF Ltd., Cosmo First Ltd., CSL Finance Ltd., Deccan Bearings Ltd … ., Lic Housing Finance Ltd., Mankind Pharma Ltd., Medi Assist Healthcare Services …